Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

6.01
+0.12002.04%
Volume:710.17K
Turnover:4.14M
Market Cap:597.68M
PE:-2.76
High:6.02
Open:5.83
Low:5.62
Close:5.89
52wk High:13.15
52wk Low:4.91
Shares:99.45M
Float Shares:48.03M
Volume Ratio:1.60
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1757
EPS(LYR):-1.7400
ROE:-210.35%
ROA:-48.02%
PB:47.77
PE(LYR):-3.45

Loading ...

ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith Files Initial Beneficial Ownership Statement

Reuters
·
Aug 18

ARS Pharmaceuticals Lawsuit Focuses on Alleged Neffy Coverage Disclosures and SPRY Stock Drop

TIPRANKS
·
Aug 15

ARS Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $18 from $24

THOMSON REUTERS
·
Aug 14

ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises

MT Newswires Live
·
Aug 14

ARS Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

ARS Pharmaceuticals Q2 Neffy Revenue Rises as Epinephrine Market Share Doubles

Reuters
·
Aug 14

ARS Pharmaceuticals Q2 EPS $(0.63) Misses $(0.48) Estimate, Sales $33.658M Beat $31.321M Estimate

Benzinga Earnings
·
Aug 14

ARS Pharmaceuticals Q2 EPS USD -0.63

THOMSON REUTERS
·
Aug 14

ARS Pharmaceuticals - Realigns Commercial Investment; Expects Cash Flow Breakeven by End of 2027

THOMSON REUTERS
·
Aug 14

Press Release: ARS Pharmaceuticals Outlines Strategic Priorities, Including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 14

ARS Pharmaceuticals Lawsuit Alleges Investors Were Misled Before SPRY Stock Drop

TIPRANKS
·
Aug 08

ARS Pharmaceuticals Schedules Conference Call to Report Q2 2026 Results

Reuters
·
Aug 03

ARS Pharma Names President Donn Casale CEO, Replacing Co-founder Richard Lowenthal

Reuters
·
Jul 08

ARS Pharmaceuticals - Richard Lowenthal to Step Down as CEO

THOMSON REUTERS
·
Jul 08

ARS Pharmaceuticals - Appoints Donn Casale as CEO and Director

THOMSON REUTERS
·
Jul 08

Press Release: ARS Pharmaceuticals Announces CEO Succession

Dow Jones
·
Jul 08

ARS Pharma Shareholders Elect Directors at Annual Meeting

Reuters
·
Jun 26

ARS Pharmaceuticals Down over 24%, on Track for Largest Percent Decrease Since September 2023

Dow Jones
·
Jun 26

ARS Pharmaceuticals is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jun 26

ARS Pharma Tumbles as Allergy Nasal Spray Faces Insurance Coverage Hurdle

Reuters
·
Jun 25